跳至主要内容
临床试验/NCT02246777
NCT02246777已完成不适用

Assessment of Efficacy and Safety of the EX-PRESS® Glaucoma Filtration Device in Patients With Normal Tension Glaucoma

Alcon Research1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2014年2月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
1
主要终点
Percentage of Eyes With IOP Lowering Rate of 20% or More From Baseline up to Month 12

研究概览

简要总结

The purpose of this study is to assess the efficacy and safety of the Alcon Ex-PRESS® Glaucoma Filtration Device (Ex-PRESS) in Japanese subjects with normal tension glaucoma.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosis of normal tension glaucoma.
  • •Indicated for filtration surgery using Ex-PRESS®.
  • •Understand and provide Informed Consent.
  • •Other protocol-defined inclusion criteria may apply.

排除标准

  • •Women who are pregnant, lactating, or planning to be pregnant during the study period.
  • •Diagnosis of angle closure glaucoma or secondary glaucoma.
  • •History of glaucoma surgery.
  • •Ophthalmologic surgery within the past 6 months.
  • •Difficulty with applanation tonometry measurement.
  • •Corneal dystrophy.
  • •Infectious/non-infectious conjunctivitis, keratitis, or uveitis in either eye.
  • •Severe blepharitis or dry eye.
  • •History of metal allergy.
  • •Other protocol-defined exclusion criteria may apply.

研究组 & 干预措施

Ex-PRESS

Experimental

Ex-PRESS® Glaucoma Filtration Device, Model P50PL, implanted in the anterior chamber of the study eye during glaucoma surgery intended for the lifetime of the patient

干预措施: Ex-PRESS® Glaucoma Filtration Device, Model P50PL (Device)

结局指标

主要结局

Percentage of Eyes With IOP Lowering Rate of 20% or More From Baseline up to Month 12

时间窗: Baseline (Pre-Operative), Month 3, Month 6, Month 12 Post-Operative

IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in mmHg. A higher IOP can be a greater risk factor for developing glaucoma or glaucoma progression (leading to optic nerve damage). Only one eye contributed to the analysis.

Percent Change From Baseline in IOP

时间窗: Baseline (Pre-Operative), Month 3, Month 6, Month 12 Post-Operative

IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in mmHg. A higher IOP can be a greater risk factor for developing glaucoma or glaucoma progression (leading to optic nerve damage). A more negative percent change from baseline indicates a greater improvement, i.e., a reduction of IOP. Only one eye contributed to the analysis.

Change From Baseline in IOP

时间窗: Baseline (Pre-Operative), Month 3, Month 6, Month 12 Post-Operative

IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in mmHg. A higher IOP can be a greater risk factor for developing glaucoma or glaucoma progression (leading to optic nerve damage). A more negative change from baseline indicates a greater improvement, i.e., a reduction of IOP. Only one eye contributed to the analysis.

Percentage of Eyes Receiving Secondary Surgical Treatment (Including Laser Therapy) Necessary to Maintain the IOP

时间窗: Month 3, Month 6, Month 12 Post-Operative

IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in mmHg. A higher IOP can be a greater risk factor for developing glaucoma or glaucoma progression (leading to optic nerve damage). Secondary surgical treatment included needling, laser suture lysis, and conjunctival and scleral flap sutures. For some subjects, both left and right eyes were targeted for the study, and data from both eyes were analyzed for this safety endpoint, as specified in the protocol. An eye may have received more than one procedure.

Mean Intraocular Pressure (IOP)

时间窗: Month 3, Month 6, Month 12 Post-Operative

IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in mmHg. A higher IOP can be a greater risk factor for developing glaucoma or glaucoma progression (leading to optic nerve damage). Only one eye contributed to the analysis.

Percentage of Eyes Receiving Drug Therapy for Glaucoma Necessary to Maintain the IOP

时间窗: Month 3, Month 6, Month 12 Post-Operative

IOP (fluid pressure inside the eye) was assessed using Goldmann applanation tonometry and reported in mmHg. A higher IOP can be a greater risk factor for developing glaucoma or glaucoma progression (leading to optic nerve damage). For some subjects, both left and right eyes were targeted for the study, and data from both eyes were analyzed for this safety endpoint, as specified in the protocol.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Alcon® Ex-PRESS® Glaucoma Filtration Device in... | 临床试验